JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB52968

Anti-MERTK 抗体 [Y323]

Anti-MERTK antibody [Y323]

  • BOND RX™ Validated
  • RabMAb
  • Recombinant
  • KO Validated
  • 20ul selling size
  • 了解详情

5

(4 Reviews)

|

(75 Publications)

Anti-MERTK antibody [Y323] (ab52968) is a rabbit monoclonal antibody detecting MERTK in Western Blot, IP, IHC-P, IHC-Fr. Suitable for Human.

- KO validated for confirmed specificity
- Biophysical QC for unrivalled batch-batch consistency
- Over 60 publications
- Trusted since 2007

查看别名

MER, MERTK, Tyrosine-protein kinase Mer, Proto-oncogene c-Mer, Receptor tyrosine kinase MerTK

10 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MERTK antibody [Y323] (AB52968)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MERTK antibody [Y323] (AB52968)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human tonsil tissue labeling MERTK with purified ab52968 at 1/500.

Heat mediated antigen retrieval was performed using Tris/EDTA buffer pH 9. ab97051 a HRP-conjugated goat anti-rabbit IgG (H+L) was used as the secondary antibody (1/500). Counterstained with hematoxylin.

Negative control using PBS instead of primary antibody (Inset).

Immunohistochemistry (Frozen sections) - Anti-MERTK antibody [Y323] (AB52968)
  • IHC-Fr

Collaborator

Immunohistochemistry (Frozen sections) - Anti-MERTK antibody [Y323] (AB52968)

IHC image of MERTK staining in a section of frozen normal human spleen performed on a Leica BONDTM system using the standard protocol. The section was fixed in 10% paraformaldehyde (10 min) prior to staining. The section was incubated with ab52968, 1/1000 dilution, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX. The inset secondary-only control image is taken from an identical assay without primary antibody.

For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MERTK antibody [Y323] (AB52968)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MERTK antibody [Y323] (AB52968)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human lymphoma tissue labeling MERTK with unpurified ab52968 at a 1/50 dilution.

Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.

Immunoprecipitation - Anti-MERTK antibody [Y323] (AB52968)
  • IP

Unknown

Immunoprecipitation - Anti-MERTK antibody [Y323] (AB52968)

Lane 1 : ab52968 (purified) at 1/20 immunoprecipitating MERTK in HEK-293 (Human epithelial cell line from embryonic kidney) cell lysate.

Lane 2 - PBS.

For western blotting, a HRP-conjugated anti-rabbit IgG, specific to the non-reduced form of IgG was used as the secondary antibody (1/1500).
Blocking/Dilution buffer and concentration : 5% NFDM/TBST.

All lanes:

Immunoprecipitation - Anti-MERTK antibody [Y323] (ab52968)

Predicted band size: 110 kDa

Observed band size: 140-180 kDa

false

Western blot - Anti-MERTK antibody [Y323] (AB52968)
  • WB

Lab

Western blot - Anti-MERTK antibody [Y323] (AB52968)

Western blot : Anti-MERTK antibody [Y323] (ab52968) staining at 1/1000 dilution, shown in green; Mouse anti-GAPDH antibody [6C5] (ab8245) loading control staining at 1/20000 dilution, shown in magenta. In Western blot, ab52968 was shown to bind specifically to MERTK. A band was observed at 160 kDa in wild-type A549 cell lysates with no signal observed at this size in MERTK knockout cell line. To generate this image, wild-type and MERTK knockout A549 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.

All lanes:

Western blot - Anti-MERTK antibody [Y323] (ab52968) at 1/1000 dilution

Lane 1:

Wild-type A549 cell lysate at 20 µg

Lane 2:

MERTK knockout A549 cell lysate at 20 µg

Lane 2:

Western blot - Human MERTK knockout A549 cell line (<a href='/products/cell-lines/human-mertk-knockout-a549-cell-line-ab301074'>ab301074</a>)

Lane 3:

HAP1 cell lysate at 20 µg

Lane 4:

HeLa cell lysate at 20 µg

Secondary

All lanes:

Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution

Observed band size: 160 kDa

false

Western blot - Anti-MERTK antibody [Y323] (AB52968)
  • WB

Lab

Western blot - Anti-MERTK antibody [Y323] (AB52968)

Blocking/Dilution buffer and concentration : 5% NFDM/TBST.

All lanes:

Western blot - Anti-MERTK antibody [Y323] (ab52968) at 1/2000 dilution

Lane 1:

HEK-293 (Human epithelial cell line from embryonic kidney) cell lysate at 20 µg

Lane 2:

K562 (Human chronic myelogenous leukemia cell line from bone marrow) cell lysate at 20 µg

Secondary

All lanes:

Peroxidase-conjugated goat anti-rabbit IgG at 1/1000 dilution

Predicted band size: 110 kDa

Observed band size: 140-180 kDa

false

Western blot - Anti-MERTK antibody [Y323] (AB52968)
  • WB

Lab

Western blot - Anti-MERTK antibody [Y323] (AB52968)

Lanes 1 - 2 : Merged signal (red and green). Green - ab52968 observed at 110 kDa. Red - loading control, ab8245, observed at 37 kDa.

ab52968 was shown to specifically react with MERTK in wild-type HAP1 cells as signal was lost in MERTK knockout cells. Wild-type and MERTK knockout samples were subjected to SDS-PAGE. The membrane was blocked with 0. ab52968 and ab8245 (Mouse anti GAPDH loading control) were incubated overnight at 4°C at 1/500 dilution and 1/20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed ab216776 secondary antibodies at 1/20000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-MERTK antibody [Y323] (ab52968) at 1/500 dilution

Lane 1:

Wild-type HAP1 whole cell lysate at 20 µg

Lane 2:

MERTK knockout HAP1 whole cell lysate at 20 µg

Predicted band size: 110 kDa

false

Western blot - Anti-MERTK antibody [Y323] (AB52968)
  • WB

AbReview28488****

Western blot - Anti-MERTK antibody [Y323] (AB52968)

ab52968 used at a 1/200 dilution, 18 hours at 4°C, 5% BSA in Tween PBS.

Positive cell line : A172

Negative cell lines : CV1 and HeLa.

Secondary used is a goat anti-rabbit polyclonal-HRP at 1/10000 dilution.

Blocked with 5% milk for 1 hour at RT.

All lanes:

Western blot - Anti-MERTK antibody [Y323] (ab52968)

Predicted band size: 110 kDa

true

Exposure time: 30s

Western blot - Anti-MERTK antibody [Y323] (AB52968)
  • WB

Unknown

Western blot - Anti-MERTK antibody [Y323] (AB52968)

All lanes:

Western blot - Anti-MERTK antibody [Y323] (ab52968) at 1/1000 dilution

All lanes:

HEK-293 (Human epithelial cell line from embryonic kidney) cell lysate at 10 µg

Secondary

All lanes:

HRP-conjugated goat anti-rabbit IgG at 1/2000 dilution

Predicted band size: 110 kDa

Observed band size: 180 kDa

false

Western blot - Anti-MERTK antibody [Y323] (AB52968)
  • WB

CiteAb

Western blot - Anti-MERTK antibody [Y323] (AB52968)

MERTK western blot using anti-MERTK antibody [Y323] ab52968. Publication image and figure legend from Frejno, M., Zenezini Chiozzi, R., et al., 2017, Mol Syst Biol, PubMed 29101300.

ab52968 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab52968 please see the product overview.

MERTK is a prognostic marker in CRC patientsWestern blot visualising MERTK expression in two negative (RKO and CC07) and two positive control cell lines (CaCo‐2 and HT55).IHC staining of MERTK expression in RKO (negative control) and CaCo‐2 (positive control) cells.IHC staining of three representative TMAs from patients enrolled in the QUASAR 2 clinical trial and the corresponding quantification of the signal by pathologists. Arrowheads indicate tumour cells positive for MERTK.Kaplan–Meier plots showing worse overall, disease‐free and recurrence‐free survival of patients with high cytoplasmic/membranous expression of MERTK. P‐values indicate the significance of MERTK as a predictor based on the Wald statistic.

false

不同偶联物与剂型 (8)

关键信息

宿主种属

Rabbit

克隆

Monoclonal

克隆号

Y323

亚型

IgG

不含载体蛋白

No

反应种属

Human

应用

IHC-Fr, IHC-P, IP, WB

applications

免疫原

The exact immunogen used to generate this antibody is proprietary information.

反应性数据

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "IHCFr" : {"fullname" : "Immunohistochemistry (Frozen sections)", "shortname":"IHC-Fr"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/20", "IP-species-notes": "<p><strong>For unpurified use at 1/50.</strong></p>", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "1/40 - 1/50", "FlowCyt-species-notes": "<p>(paraformaldehyde or methanol fixed cells)</p><p><a href='/products/primary-antibodies/rabbit-igg-monoclonal-epr25a-isotype-control-ab172730'>ab172730</a> - Rabbit monoclonal IgG, is suitable for use as an isotype control with this antibody.</p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/2000", "WB-species-notes": "<p><strong>For unpurified use at 1/500.</strong></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>", "IHCFr-species-checked": "testedAndGuaranteed", "IHCFr-species-dilution-info": "", "IHCFr-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/1000 - 1/2000", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol." } } }

产品详情

What is this antibody validated in?
Anti-MERTK antibody [Y323] (ab52968) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Immunoprecipitation (IP), Immunohistochemistry (IHC-P), Immunohistochemistry (IHC-Fr) in Human samples.

Trusted by the scientific community
Anti-MERTK [Y323] (ab52968) was first used in a scientific publication in 2007 and has been cited over 60 times in peer-reviewed journals.

Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.

Specificity confirmed
The specificity of Anti-MERTK antibody [Y323] (ab52968) has been confirmed by Western blot testing in MERTK Knockout HAP1 cells.

Other related products
We have a range of other formats of antibody clone [Y323] also available for your convenience: ab52968, Carrier free - ab176887, HRP - ab197643, Carrier free - ab271851, Alexa Fluor® 647 - ab305049, Alexa Fluor® 555 - ab305368, Alexa Fluor® 488 - ab307385, Alexa Fluor® 594 - ab311784, Alexa Fluor® 568 - ab313065, Alexa Fluor® 750 - ab321677

Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

性能和储存信息

形式
Liquid
纯化工艺
Affinity purification Protein A
存储溶液
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
运输条件
Blue Ice
推荐的短期储存时间
1-2 weeks
推荐的短期储存条件
+4°C
推荐的长期储存条件
-20°C
分装信息
Upon delivery aliquot
储存信息
Avoid freeze / thaw cycle

补充信息

This supplementary information is collated from multiple sources and compiled automatically.

The MERTK protein also known as c-Mer tyrosine kinase plays a mechanical role as a receptor tyrosine kinase with a mass of approximately 110 kDa. It is expressed in multiple tissues including the retina immune cells and some epithelial cells. MERTK functions by binding with its ligands facilitating downstream signaling that affects cellular functions. The receptor is part of the TAM family alongside proteins like AXL and TYRO3.
Biological function summary

The receptor MERTK orchestrates processes critical for maintaining cellular homeostasis such as efferocytosis and immune response regulation. It does not operate alone but often interacts with other cellular components to form functional complexes. This protein contributes significantly to phagocytosis a cellular process for clearing apoptotic cells ensuring a controlled immune environment.

Pathways

Several signal transduction pathways involve c-Mer tyrosine kinase in maintaining cellular communication. Notably it participates in the RAS/MAPK and PI3K/AKT pathways which are essential for cell survival and proliferation. These pathways involve interactions with proteins such as GAB1 and SOS highlighting the receptor's integration in cell signaling networks.

Aberrant activity of MERTK has associations with cancer and autoimmune disorders. In cancers such as leukemia overexpression of the MERTK protein promotes cell survival and proliferation. Its interaction with other proteins like GRB2 can further exacerbate oncogenic pathways. In autoimmune diseases dysregulated MERTK expression can lead to improper clearance of apoptotic cells contributing to systemic inflammation.

产品实验方案

For this product, it's our understanding that no specific protocols are required. You can visit:

靶点信息

Receptor tyrosine kinase that transduces signals from the extracellular matrix into the cytoplasm by binding to several ligands including LGALS3, TUB, TULP1 or GAS6. Regulates many physiological processes including cell survival, migration, differentiation, and phagocytosis of apoptotic cells (efferocytosis). Ligand binding at the cell surface induces autophosphorylation of MERTK on its intracellular domain that provides docking sites for downstream signaling molecules. Following activation by ligand, interacts with GRB2 or PLCG2 and induces phosphorylation of MAPK1, MAPK2, FAK/PTK2 or RAC1. MERTK signaling plays a role in various processes such as macrophage clearance of apoptotic cells, platelet aggregation, cytoskeleton reorganization and engulfment (PubMed : 32640697). Functions in the retinal pigment epithelium (RPE) as a regulator of rod outer segments fragments phagocytosis. Also plays an important role in inhibition of Toll-like receptors (TLRs)-mediated innate immune response by activating STAT1, which selectively induces production of suppressors of cytokine signaling SOCS1 and SOCS3.
See full target information MERTK

文献 (75)

Recent publications for all applications. Explore the full list and refine your search

Blood vessels, thrombosis & hemostasis 2:100078 PubMed40918742

2025

iMer, a naturally occurring MERTK splice variant, binds to GAS6 to decrease platelet activation and thrombus formation.

Applications

Unspecified application

Species

Unspecified reactive species

Stephanie Springborn,Samantha Judd,Patricia Morateck,David VanderZee,Adam Kidwell,Christine Brzezinski,Allaura Cox,Susan Sather,Keith B Neeves,Deborah DeRyckere,Jorge Di Paola,Douglas K Graham,Brian R Branchford

Scientific reports 15:23065 PubMed40595270

2025

Clinical significance of TAM receptor in the minor salivary glands of patients with Sjögren's disease.

Applications

Unspecified application

Species

Unspecified reactive species

Sung-Eun Choi,Ji-Hyoun Kang,Dong-Jin Park,Nah Ihm Kim,Ji Shin Lee,Kyung Chul Yoon,Shin-Seok Lee

Experimental and therapeutic medicine 29:110 PubMed40242601

2025

Repurposing of the Syk inhibitor fostamatinib using a machine learning algorithm.

Applications

Unspecified application

Species

Unspecified reactive species

Yoonjung Choi,Heejin Lee,Bo Ram Beck,Bora Lee,Ji Hyun Lee,Seoree Kim,Sang Hoon Chun,Hye Sung Won,Yoon Ho Ko

International journal of oral science 17:18 PubMed40075093

2025

Administration of Porphyromonas gingivalis in pregnant mice enhances glycolysis and histone lactylation/ADAM17 leading to cleft palate in offspring.

Applications

Unspecified application

Species

Unspecified reactive species

Xige Zhao,Xiaoyu Zheng,Yijia Wang,Jing Chen,Xiaotong Wang,Xia Peng,Dong Yuan,Ying Liu,Zhiwei Wang,Juan Du

Investigative ophthalmology & visual science 65:23 PubMed39535788

2024

Genetic and Cellular Basis of Impaired Phagocytosis and Photoreceptor Degeneration in CLN3 Disease.

Applications

Unspecified application

Species

Unspecified reactive species

Jimin Han,Sueanne Chear,Jana Talbot,Vicki Swier,Clarissa Booth,Cheyenne Reuben-Thomas,Sonal Dalvi,Jill M Weimer,Alex W Hewitt,Anthony L Cook,Ruchira Singh

Science advances 10:eado8366 PubMed39365866

2024

MerTK macrophages promote melanoma progression and immunotherapy resistance through AhR-ALKAL1 activation.

Applications

Unspecified application

Species

Unspecified reactive species

Naming Wu,Jun Li,Lu Li,Liu Yang,Liyun Dong,Chen Shen,Shanshan Sha,Yangxue Fu,Enzhu Dong,Fang Zheng,Zheng Tan,Juan Tao

Cancers 16: PubMed39199601

2024

MERTK Is a Potential Therapeutic Target in Ewing Sarcoma.

Applications

Unspecified application

Species

Unspecified reactive species

Sherri K Smart,Tsz Y Yeung,M Olivia Santos,Leon F McSwain,Xiaodong Wang,Stephen V Frye,H Shelton Earp,Deborah DeRyckere,Douglas K Graham

iScience 27:110226 PubMed39021800

2024

Osteopontin regulation of MerTK macrophages promotes Crohn's disease intestinal fibrosis.

Applications

Unspecified application

Species

Unspecified reactive species

Juanhan Liu,Wenbin Gong,Peizhao Liu,Yangguang Li,Haiyang Jiang,Cunxia Wu,Xiuwen Wu,Yun Zhao,Jianan Ren

Cancers 16: PubMed38927958

2024

Targeting Tyro3, Axl, and MerTK Receptor Tyrosine Kinases Significantly Sensitizes Triple-Negative Breast Cancer to CDK4/6 Inhibition.

Applications

Unspecified application

Species

Unspecified reactive species

Seyma Demirsoy,Ha Tran,Joseph Liu,Yunzhan Li,Shengyu Yang,Dawit Aregawi,Michael J Glantz,Naduparambil K Jacob,Vonn Walter,Todd D Schell,Inan Olmez

International journal of molecular sciences 25: PubMed38791148

2024

MerTK Drives Proliferation and Metastatic Potential in Triple-Negative Breast Cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Mari Iida,Bridget E Crossman,Kourtney L Kostecki,Christine E Glitchev,Carlene A Kranjac,Madisen T Crow,Jillian M Adams,Peng Liu,Irene Ong,David T Yang,Irene Kang,Ravi Salgia,Deric L Wheeler
View all publications

Abcam Product Promise

我们致力于为您的研究提供高质量的试剂,为您科研的每一步提供支持。若我们的产品未能达到预期性能,我们向您提供 Abcam Product Promise 保障。
详情请参阅我们的条款与条件。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com